Aucta Pharmaceuticals
FDA Approved Drugs

Aucta Pharmaceuticals

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 12
  • Latest Approval Date Apr 09, 2026
  • Data Source FDA
  • First Approval Date Mar 09, 2021
Company Overview

Company

Aucta Pharmaceuticals

Country

U.S.A

Email

Social Profiles

LinkedIn
Company Snapshot

Aucta Pharmaceuticals

71 Suttons Lane, Piscataway, NJ 08854

U.S.A

www.auctapharma.com/ View on Map
FDA Approved Drug Records ( 12 records )
2025
03 Feb
RX Application: 218380

Drug Name

ARFORMOTEROL TARTRATE

Product Number

1

Dosage Form

-

Strength

EQ 0.015MG BASE/2ML

Approval Date

2025-02-03

218380 / 1

Active Ingredient

ARFORMOTEROL TARTRATE

Application Number

218380

Product Number

1

Dosage Form

-

Strength

EQ 0.015MG BASE/2ML

Approval Date

2025-02-03

Regulatory Status

RX

2021
09 Mar
RX Application: 214559

Drug Name

DEFERASIROX

Product Number

1

Dosage Form

-

Strength

90MG

Approval Date

2021-03-09

214559 / 1

Active Ingredient

DEFERASIROX

Application Number

214559

Product Number

1

Dosage Form

-

Strength

90MG

Approval Date

2021-03-09

Regulatory Status

RX

2021
09 Mar
RX Application: 214559

Drug Name

DEFERASIROX

Product Number

2

Dosage Form

-

Strength

180MG

Approval Date

2021-03-09

214559 / 2

Active Ingredient

DEFERASIROX

Application Number

214559

Product Number

2

Dosage Form

-

Strength

180MG

Approval Date

2021-03-09

Regulatory Status

RX

2021
09 Mar
RX Application: 214559

Drug Name

DEFERASIROX

Product Number

3

Dosage Form

-

Strength

360MG

Approval Date

2021-03-09

214559 / 3

Active Ingredient

DEFERASIROX

Application Number

214559

Product Number

3

Dosage Form

-

Strength

360MG

Approval Date

2021-03-09

Regulatory Status

RX

2026
09 Apr
RX Application: 217772

Drug Name

FOSFOMYCIN TROMETHAMINE

Product Number

1

Dosage Form

-

Strength

EQ 3GM BASE/PACKET

Approval Date

2026-04-09

217772 / 1

Active Ingredient

FOSFOMYCIN TROMETHAMINE

Application Number

217772

Product Number

1

Dosage Form

-

Strength

EQ 3GM BASE/PACKET

Approval Date

2026-04-09

Regulatory Status

RX

2023
04 May
RX Application: 216185

Drug Name

MOTPOLY XR

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2023-05-04

216185 / 1

Active Ingredient

LACOSAMIDE

Application Number

216185

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2023-05-04

Regulatory Status

RX

2023
04 May
RX Application: 216185

Drug Name

MOTPOLY XR

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2023-05-04

216185 / 2

Active Ingredient

LACOSAMIDE

Application Number

216185

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2023-05-04

Regulatory Status

RX

2023
04 May
RX Application: 216185

Drug Name

MOTPOLY XR

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

2023-05-04

216185 / 3

Active Ingredient

LACOSAMIDE

Application Number

216185

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

2023-05-04

Regulatory Status

RX

2022
30 Nov
RX Application: 215332

Drug Name

OXCARBAZEPINE

Product Number

1

Dosage Form

-

Strength

300MG/5ML

Approval Date

2022-11-30

215332 / 1

Active Ingredient

OXCARBAZEPINE

Application Number

215332

Product Number

1

Dosage Form

-

Strength

300MG/5ML

Approval Date

2022-11-30

Regulatory Status

RX

2025
30 Jun
RX Application: 219417

Drug Name

PYQUVI

Product Number

1

Dosage Form

-

Strength

22.75MG/ML

Approval Date

2025-06-30

219417 / 1

Active Ingredient

DEFLAZACORT

Application Number

219417

Product Number

1

Dosage Form

-

Strength

22.75MG/ML

Approval Date

2025-06-30

Regulatory Status

RX

2025
29 Apr
RX Application: 218645

Drug Name

ZELVYSIA

Product Number

1

Dosage Form

-

Strength

100MG/PACKET

Approval Date

2025-04-29

218645 / 1

Active Ingredient

SAPROPTERIN DIHYDROCHLORIDE

Application Number

218645

Product Number

1

Dosage Form

-

Strength

100MG/PACKET

Approval Date

2025-04-29

Regulatory Status

RX

2025
29 Apr
RX Application: 218645

Drug Name

ZELVYSIA

Product Number

2

Dosage Form

-

Strength

500MG/PACKET

Approval Date

2025-04-29

218645 / 2

Active Ingredient

SAPROPTERIN DIHYDROCHLORIDE

Application Number

218645

Product Number

2

Dosage Form

-

Strength

500MG/PACKET

Approval Date

2025-04-29

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    12 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
12 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ARFORMOTEROL TARTRATE

Application Number

218380

Product Number

1

Active Ingredient

ARFORMOTEROL TARTRATE

Dosage Form

-

Strength

EQ 0.015MG BASE/2ML

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.